By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at ...
Spatial maps of lung precancer and cancer cells at different points in development advance understanding of the earliest ...
Alecensa achieved a 4-year OS rate of 98.4% in resected ALK-positive early-stage NSCLC, outperforming chemotherapy. The ALINA study showed a 65% reduction in disease recurrence or death risk with ...
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...
The American Lung Association released its State of Lung Cancer report, noting the five-year survival rate has gone from 18% ...
Lung cancer is the leading cause of cancer-related deaths in the United States. As we start Lung Cancer Awareness Month, a ...
Persistent cough, fatigue, and breathlessness symptoms like these can point to either pneumonia or lung cancer. Experts say ...
Amgen Inc ( (AMGN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Amgen Inc ( (AMGN) ), BeOne Medicines ( (ONC)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback